Antileukemic effects of piperlongumine and alpha lipoic acid combination on Jurkat, MEC1 and NB4 cells in vitro

Journal of Cancer Research and Therapeutics

Volumn 12, Issue 2, 2016, Pages 556-560

  Alpay, Merve ^a   Yurdakok Dikmen, Begum ^b   Kismali, Gorkem ^b   Sel, Tevhide ^b  

^a DUZCE UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

Alpha lipoic acid; COX 2; leukemic cell lines; oxidative stress; piperlongumine

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ALKALOID; ANTILEUKEMIC AGENT; CASPASE 3; CYCLOOXYGENASE 2; PIPERLONGUMINE; THIOCTIC ACID; UNCLASSIFIED DRUG; 1,3 DIOXOLANE DERIVATIVE; ANTINEOPLASTIC AGENT; PIPERLONGUMININE;

ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENTIATION; ENZYME ACTIVITY; ENZYME INDUCTION; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; JURKAT CELL LINE; LEUKEMIA; MALE; MIDDLE AGED; MTT ASSAY; PROMYELOCYTIC LEUKEMIA; PROTEIN CLEAVAGE; T CELL LEUKEMIA; APOPTOSIS; CELL SURVIVAL; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; METABOLISM; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CELL LINE, TUMOR; CELL SURVIVAL; CYCLOOXYGENASE 2; DIOXOLANES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; JURKAT CELLS; LEUKEMIA; THIOCTIC ACID;

EID: 84979998520     PISSN: 09731482     EISSN: 19984138     Source Type: Journal    
DOI: 10.4103/0973-1482.151936     Document Type: Article

References (28)

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014;64: 9-29.
2. National Cancer Institute at the National Institutes of Health in United States. Available from: http: //www. cancer. gov/cancertopics/ types/leukemia [Last accessed on 2014 Sep 4].
3. Lucas DM, Still PC, Pérez LB, Grever MR, Kinghorn AD. Potential of plant derived natural products in the treatment of leukemia and lymphoma. Curr Drug Targets 2010;11: 812-22.
4. Lingadurai S, Roy S, Joseph RV, Nath LK. Antileukemic activity of the leaf extract of Bischofia javanica blume on human leukemic cell lines. Indian J Pharmacol 2011;43: 143-9.
5. Bezerra DP, Pessoa C, de Moraes MO, Saker-Neto N, Silveira ER, Costa-Lotufo LV. Overview of the therapeutic potential of piplartine (piperlongumine). Eur J Pharm Sci 2013;48: 453-63.
6. Liu Y, Chang Y, Yang C, Sang Z, Yang T, Ang W, et al. Biodegradable nanoassemblies of piperlongumine display enhanced anti angiogenesis and anti tumor activities. Nanoscale 2014;6: 4325-37.
7. Adams DJ, Dai M, Pellegrino G, Wagner BK, Stern AM, Shamji AF, et al. Synthesis, cellular evaluation, and mechanism of action of piperlongumine analogs. Proc Natl Acad Sci U S A 2012;109: 15115-20.
8. Lanotte M, Martin-Thouvenin V, Najman S, Balerini P, Valensi F, Berger R. NB4, a maturation inducible cell line with t (15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 1991;77: 1080-6.
9. Guan L, Han B, Li J, Li Z, Huang F, Yang Y, et al. Exposure of human leukemia NB4 cells to increasing concentrations of selenite switches the signaling from pro survival to pro apoptosis. Ann Hematol 2009;88: 733-42.
10. Stacchini A, Aragno M, Vallario A, Alfarano A, Circosta P, Gottardi D, et al. MEC1 and MEC2: Two new cell lines derived from B chronic lymphocytic leukaemia in prolymphocytoid transformation. Leuk Res 1999;23: 127-36.
11. Rasul E, Salamon D, Nagy N, Leveau B, Banati F, Szenthe K, et al. The MEC1 and MEC2 lines represent two CLL subclones in different stages of progression towards prolymphocytic leukemia. PLoS One 2014;9: e106008.
12. Alomari M, Mactier S, Kaufman KL, Best OG, Mulligan SP. Profiling the lipid raft proteome from human MEC1 chronic lymphocytic leukemia cells. J Proteomics Bioinform 2014;S7: 005.
13. Schneider U, Schwenk HU, Bornkamm G. Characterization of EBV genome negative "null" and "T" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non Hodgkin lymphoma. Int J Cancer 1977;19: 521-6.
14. Zhang SJ, Ge QF, Guo DW, Hu WX, Liu HZ. Synthesis and anticancer evaluation of alpha lipoic acid derivatives. Bioorg Med Chem Lett 2010;20: 3078-83.
15. Saeidnia S, Abdollahi M. Antioxidants: Friends or foe in prevention or treatment of cancer: The debate of the century. Toxicol Appl Pharmacol 2013;271: 49-63.
16. Mosmann T. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65: 55-63.
17. Wenzel U, Nickel A, Daniel H. Alpha Lipoic acid induces apoptosis in human colon cancer cells by increasing mitochondrial respiration with a concomitant O2generation. Apoptosis 2005;10: 359-68.
18. Shi DY, Liu HL, Stern JS, Yu PZ, Liu SL. Alpha lipoic acid induces apoptosis in hepatoma cells via the PTEN/Akt pathway. FEBS Lett 2008;582: 1667-71.
19. Pack RA, Hardy K, Madigan MC, Hunt NH. Differential effects of the antioxidant alpha lipoic acid on the proliferation of mitogen stimulated peripheral blood lymphocytes and leukaemic Tcells. Mol Immunol 2002;38: 733-45.
20. Sen CK, Sashwati R, Packer L. Fas mediated apoptosis of human Jurkat T cells: Intracellular events and potentiation by redox active alpha lipoic acid. Cell Death Differ 1999;6: 481-91.
21. Mikirova N, Jackson J, Riordan N. Differential effect of alpha lipoic acid on healthy peripheral blood lymphocytes and leukemic cells. J Orthomol Med 2008;23: 83-9.
22. Ha H, Lee JH, Kim HN, Kim HM, Kwak HB, Lee S, et al. Alpha Lipoic acid inhibits inflammatory bone resorption by suppressing prostaglandin E2 synthesis. J Immunol 2006;176: 111-7.
23. Egyudova K, Siltanen A, Kankuri E, Bizik J. Leukemic cells modulate induction of COX 2 in human stromal fibroblasts. Neoplasma 2011;58: 525-31.
24. Chandramohan Reddy T, Bharat Reddy D, Aparna A, Arunasree KM, Gupta G, Achari C, et al. Anti leukemic effects of gallic acid on human leukemia K562 cells: Downregulation of COX 2, inhibition of BCR/ABL kinase and NFB inactivation. Toxicol In Vitro 2012;26: 396-405.
25. Ai L, Kim W, Alpay M, Stratford May W, Erin Siegel, Kevin D Brown. TRIM29 suppresses TWIST1 and invasive breast cancer behavior. Cancer Res 2014. DOI: 10. 1158/0008-5472. CAN-13-3579.
26. Nakamura S, Kobayashi M, Shibata K, Sahara N, Shigeno K, Shinjo K et al. COX-2 independent induction of apoptosis by etodolac in leukemia cells in vitro and growth inhibition of leukemia cells in vivo. Cancer Ther 2004;2: 153-66.
27. Shams TM, Atwa MM, Shams ME. Negative correlation between caspase-3 and COX-2 expression in colon cancer: An immunohistochemical study. Egypt J Pathol 2012;32: 68-74.
28. Kong EH, Kim YJ, Kim YJ, Cho HJ, Yu SN, Kim KY, et al. Piplartine induces caspase-mediated apoptosis in PC-3 human prostate cancer cells. Oncol Rep 2008;20: 785-92.